EP1360050B1 - Method to produce nasal and oral cannula breathing detection devices - Google Patents

Method to produce nasal and oral cannula breathing detection devices Download PDF

Info

Publication number
EP1360050B1
EP1360050B1 EP01992093.3A EP01992093A EP1360050B1 EP 1360050 B1 EP1360050 B1 EP 1360050B1 EP 01992093 A EP01992093 A EP 01992093A EP 1360050 B1 EP1360050 B1 EP 1360050B1
Authority
EP
European Patent Office
Prior art keywords
cannula
mandrel
forming
main body
mandrel assembly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
EP01992093.3A
Other languages
German (de)
French (fr)
Other versions
EP1360050A1 (en
EP1360050A4 (en
Inventor
James N. Curti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Salter Labs Inc
Original Assignee
Salter Labs Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/754,471 external-priority patent/US6533983B2/en
Application filed by Salter Labs Inc filed Critical Salter Labs Inc
Publication of EP1360050A1 publication Critical patent/EP1360050A1/en
Publication of EP1360050A4 publication Critical patent/EP1360050A4/en
Application granted granted Critical
Publication of EP1360050B1 publication Critical patent/EP1360050B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C41/00Shaping by coating a mould, core or other substrate, i.e. by depositing material and stripping-off the shaped article; Apparatus therefor
    • B29C41/02Shaping by coating a mould, core or other substrate, i.e. by depositing material and stripping-off the shaped article; Apparatus therefor for making articles of definite length, i.e. discrete articles
    • B29C41/22Making multilayered or multicoloured articles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/06Respiratory or anaesthetic masks
    • A61M16/0666Nasal cannulas or tubing
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C33/00Moulds or cores; Details thereof or accessories therefor
    • B29C33/44Moulds or cores; Details thereof or accessories therefor with means for, or specially constructed to facilitate, the removal of articles, e.g. of undercut articles
    • B29C33/48Moulds or cores; Details thereof or accessories therefor with means for, or specially constructed to facilitate, the removal of articles, e.g. of undercut articles with means for collapsing or disassembling
    • B29C33/485Moulds or cores; Details thereof or accessories therefor with means for, or specially constructed to facilitate, the removal of articles, e.g. of undercut articles with means for collapsing or disassembling cores or mandrels
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C41/00Shaping by coating a mould, core or other substrate, i.e. by depositing material and stripping-off the shaped article; Apparatus therefor
    • B29C41/02Shaping by coating a mould, core or other substrate, i.e. by depositing material and stripping-off the shaped article; Apparatus therefor for making articles of definite length, i.e. discrete articles
    • B29C41/14Dipping a core
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00Anatomical parts of the body
    • A61M2210/06Head
    • A61M2210/0618Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00Anatomical parts of the body
    • A61M2210/06Head
    • A61M2210/0625Mouth

Definitions

  • This invention provides a novel method of producing cannulas suitable for use in both nasal and oral applications, using disconnectable mandrel parts to form the mold over which cannula forming plastics material is applied to form the cannula.
  • This invention relates generally to cannulas adapted for both mouth and nasal use to monitor breathing, in particular, a method of manufacturing a cannula adapted to interconnect with both nasal passages and the mouth for use to monitor breathing, especially for the detection of apnea.
  • Nasal cannulas are commonly used to administer gases, such as oxygen, to humans having respiratory problems. Illustrations of nasal cannulas used for this purpose are found in United States Patent No. 3,802,431 . Nasal cannulas have been used also for inhalation therapy, made possible by development of inhalation sensors such as described in United States Patent No. 4,745,925 . A nasal cannula can be used to monitor breathing and for detection of apnea (the absence of breathing) when connected to an inhalation sensor.
  • Nasal cannulas additionally adapted to communicate with the mouth of humans to permit administration of fluids or sensing of apnea during periods of mouth breathing or nasal blockage are also known.
  • the present invention is a novel method of manufacturing a cannula to communicate with both nasal and oral passages.
  • This method provides in the preferred embodiment, disconnectable mandrels, which when assembled form a mold over which a cannula forming polymeric material is applied, and which, through the capability of being disconnected, each mandrel part from the other(s), facilitates removal of the mandrels from the formed cannula.
  • US 4106505 discloses a cannular having a body portion and a pair of nare formations, which is formed by dip moulding.
  • the cannula disclosed in this specification does not however include a mouth piece.
  • US4106505 does not include any details of the mandrel assembly used in the dip moulding process.
  • EP-A-0 933 094 discloses a cannula having a main body, first and second nares and a mouthpiece.
  • US-A-3 731 900 discloses a method of molding a nasal cannula using a unitary core or separate cores for the main body and the nasal tips.
  • Application of the plastics material over the mandrel assembly and subsequent extraction of the mandrel sections following curing of the cannula material provides a finished cannula with contiguous internal flow paths to monitor a patent's breathing.
  • Still another object of the invention is to form the main body forming mandrel as two separate, slightly spaced apart components which remain spaced apart from one another by a void, during the dipping process, so that the void becomes filled with a plastisol to form a septum or barrier which divides the internal passage into two compartments or passageways, one which facilitates the supply of supplemental oxygen to a patient while the other facilitates monitoring of the breathing of the patient.
  • a beryllium copper cannula mandrel assembly 3 is shown with nare forming mandrels 5 and 7, and a mouthpiece forming mandrel 9 with end connector 11, for joining the mouthpiece
  • mandrel 9 to the main body forming mandrel 1.
  • Shown in ghost is a cannula formed on the assembly and comprising a main body 1', a pair of nares 5', 7'and a mouthpiece 9'composed of polyvinyl chloride (PVC).
  • PVC polyvinyl chloride
  • Fig. 2 shows the mandrel assembly parts prior to assembly to produce the cannula mandrel assembly 3.
  • Nare mandrels 5 and 7 have reduced diameter sections 13 and 15 to form nares 5', 7', respectively, over which cannula material is applied.
  • Reduced diameter sections 13 and 15 of nare mandrels 5 and 7 mate slidably with blind holes 17 and 19 of main body mandrel 1.
  • Main body mandrel 1 also has a rectangular recessed section 21 to slidably mate with end connector 11 of mouthpiece mandrel 9.
  • Nare mandrels 5 and 7 also have enlarged diameter sections 23 and 25 to support the mandrel in a jig. Additionally, the enlarged diameter enables sections 23 and 25 to provide a larger contact surface to provide grip for removal of nare mandrels 5 and 7 from main body mandrel 1 after partial curing of the PVC on mandrel assembly 3.
  • Fig. 2 further shows the mouthpiece mandrel 9 with the end connector 11 which has a slot 27 to slidably engage the rectangular section 21 of the main body mandrel 1.
  • Slot 27 is sized to permit close contact of slot 27 with the rectangular section 21 of main body mandrel 1 such that a snug fit is obtained to removably retain the mouthpiece mandrel 9 on the main body mandrel 1 while facilitating extraction from rectangular section 21 following partial curing and cooling of the PVC.
  • the outer surface of end connector 11 approximates the outer diameter of main body mandrel 1 to provide a uniform diameter of applied cannula material and to facilitate withdrawal of the mouthpiece mandrel 9 from the mouthpiece 9'of the canula.
  • Fig. 3 shows mouthpiece mandrel 9 having a desired radius X and end connector 11 with slot 27.
  • Fig. 4 shows the shape of end connector 11 and slot 27 through section 4-4 of Fig. 3 .
  • blind holes 17 and 19 are sized to mate slidably with reduced diameter sections 13 and 15 of the nare mandrels 5 and 7 in order to engage and support nare mandrels 5 and 7 during application of the PVC to form the cannula on the assembly 3.
  • the rectangular section 21 is made with shoulder depth T removed to allow the diameter of end connector 11 of mouthpiece mandrel 9 to mate approximately flush with the diameter Y of main body 1.
  • Rectangular section 21 is shown with preferred relieving radii R at opposed ends of the section. Radius R may be omitted if main body mandrel 1 is machined or formed in a manner that allows this. Thickness Z of rectangular section 21 permits slot 27 of end connector 11 of mouthpiece mandrel 9 to firmly but slidably mate with rectangular section 21. Width W of rectangular section 21 is just sufficient to closely accommodate end connector 11 of mouthpiece mandrel 9.
  • Figs. 1 and 2 show nare mandrels 5 and 7 with bend sections. These bend sections direct the nares of the cannula into a patient's nasal cavities.
  • beryllium copper is the preferred material for the cannula mandrel assembly 3
  • other materials which possess appropriate working temperature ranges, retain dimensional stability for reuse in a manufacturing environment and which will release the cannula easily after curing of the PVC may be used.
  • Metals including but not limited to the steels, aluminum, bronze, brass, and copper alloys may be used, as well as some plastics.
  • Beryllium copper is preferred due to its ability to transfer heat rapidly and reliably release the cured plastics material of the cannula formed thereon. Rapid heat transfer is desirable for the mandrel material, both during heating cannula mandrel assembly 3 and following cannula material application, when a partial cure of the material is followed by rapid cooling.
  • the cannula mandrel 3 Prior to application of a latex solution of PVC (plastisol) the cannula mandrel 3 is coated, usually by dipping, with a silicone release layer to facilitate removal of the mandrel from the plastisol to be applied.
  • the application of the PVC in the preferred embodiment is by dipping the silicone coated cannula mandrel assembly 3 which has been heated in an oven at an oven temperature of from about 176.6°C (350°F) to about 290.6°C (550°F) (preferably about 232.2 °C (450°F)) for about 1 to about 3 minutes into a latex solution of PVC (plastisol).
  • One or more dipping steps may be performed to achieve the desired finished cannula material thickness and each of these dipping steps may be for 10-30 seconds.
  • the mandrel is supported by the outer end portions of the nare mandrels.
  • a latex solution of PVC (plastisol) provides a semi-clear finished cannula with strength to withstand attachment of connectors and flexibility to prevent injury to the user.
  • other plastics materials which provide material properties suitable for this method, capable of forming a plastisol may be substituted for PVC.
  • Partial curing of the cannula takes place on the mandrel assembly 3.
  • the cannula mandrel assembly with the partially cured PVC thereon is then placed in an oven a sufficient time for further curing at a temperature from about 210.0°C (410°F) to about 232.2°C (450°F).
  • the mandrel parts are removed from the cannula.
  • a cannula with two nares and a mouthpiece is formed as follows: a cannula mandrel assembly 3 is formed by first, slidably mating reduced diameter sections 13 and 15 of nare mandrels 5 and 7 with blind holes 17 and 19, respectively, of the main body mandrel1 ; second, orienting nare mandrels 5 and 7; third, slidably mating slot 27 of end connector 1-1 of the mouthpiece mandrel 9 with the rectangular section 21 of main body mandrel 1 in a desired orientation relative to nare mandrels 5 and 7; fourth, providing a silicone release layer substantially encompassing the mandrel; fifth, heating the assembled cannula mandrel assembly in an oven at a temperature of from about 176.6°C (350°F) to about 290.6°C (550°F); sixth, providing a liquid uncured latex PVC mix (plastisol); seventh, dipping the cannula mandrel assembly into
  • Fig. 7 show a finished cannula, following removal of cannula mandrel assembly 3 parts from the cured PVC, showing contiguous flow paths through the main body 1', nares 5' and 7' and mouthpiece 9'.
  • the curing step may be completed in two stages, a first partial cure of the PVC produced by the heated cannula mandrel assembly 3 sufficient to maintain the PVC on this assembly and a second step in an oven at the above curing temperatures to complete the curing of the PVC.
  • the outer ends of the main body 1' may be trimmed to provide a discrete area where connecting tubing may be connected thereto, e.g. by solvent bonding, and that the mouthpiece may be trimmed to a length suited to an individual patient so as to maximize the sensitivity of the finished device.
  • disassembly of the cannula mandrel assembly can proceed by removing the mouthpiece mandrel before the nare mandrels as obvious alternative method steps, prior to removal of the main body mandrel.
  • One modification of the present invention relates to the addition of a septum in the internal passage of the cannula to provide a barrier therein.
  • the septum 29 divides the internal passage into two compartments or passageways so that a first one of the nares 5' can be coupled to an oxygen source (not shown) to facilitate the supply of supplemental oxygen to one of the nostrils of a patient while the other one of the nares 7' and the central mouthpiece 9' can be coupled to a monitoring device (not shown), such as a transducer, to facilitate monitoring of breathing of the patient or coupled to a demand oxygen conserving device (not shown) while the patient, at the same time, is still able to receive, either continuously or intermittently during the sensed breathing cycle, a supply of oxygen.
  • a monitoring device such as a transducer
  • the main body forming mandrel 1 is formed as first and second separate, slightly spaced apart components 30,31 which remain spaced apart from one another by a void 32 during the dipping operation of the manufacturing process so that the void 32 between the first and second separate, slightly spaced apart components 30, 31 is filled with the plastisol to form the septum 29.
  • the septum 29 forms a barrier which divides the internal passage into two compartments or passageways.
  • the nare mandrels 5 and 7 are removed from the blind holes 17 and 19 of main body mandrel 1 and the nares 5', 7' by pulling on enlarged diameter sections of nare mandrels 5 and 7, the mouthpiece mandrel 9 is removed from the mouthpiece 9' by disconnecting slot 27 of end connector 11 from rectangular section 21 of main body mandrel 1 and pulling the mouthpiece mandrel 9 through the mouthpiece 9'; and the first and second spaced apart components 30, 31 of the main body mandrel 1 are removed from the main body 1' of the cannula by pulling the first and second spaced apart components 30, 31 axially away from one another.
  • This variation of the manufacturing process is suitable for intermittent nocturnal oxygen delivery even though the patient breaths through his or her mouth.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Otolaryngology (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Emergency Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Moulding By Coating Moulds (AREA)
  • Moulds For Moulding Plastics Or The Like (AREA)
  • Shaping Of Tube Ends By Bending Or Straightening (AREA)

Description

  • This invention provides a novel method of producing cannulas suitable for use in both nasal and oral applications, using disconnectable mandrel parts to form the mold over which cannula forming plastics material is applied to form the cannula.
  • BACKGROUND OF THE INVENTION
  • This invention relates generally to cannulas adapted for both mouth and nasal use to monitor breathing, in particular, a method of manufacturing a cannula adapted to interconnect with both nasal passages and the mouth for use to monitor breathing, especially for the detection of apnea.
  • Nasal cannulas are commonly used to administer gases, such as oxygen, to humans having respiratory problems. Illustrations of nasal cannulas used for this purpose are found in United States Patent No. 3,802,431 . Nasal cannulas have been used also for inhalation therapy, made possible by development of inhalation sensors such as described in United States Patent No. 4,745,925 . A nasal cannula can be used to monitor breathing and for detection of apnea (the absence of breathing) when connected to an inhalation sensor.
  • Nasal cannulas additionally adapted to communicate with the mouth of humans to permit administration of fluids or sensing of apnea during periods of mouth breathing or nasal blockage are also known.
  • The present invention is a novel method of manufacturing a cannula to communicate with both nasal and oral passages. This method provides in the preferred embodiment, disconnectable mandrels, which when assembled form a mold over which a cannula forming polymeric material is applied, and which, through the capability of being disconnected, each mandrel part from the other(s), facilitates removal of the mandrels from the formed cannula.
  • The prior art of dipping a part in a plastisol to create a coating thereof is exemplified by United States Patent Nos. 3,906,071 , 4,695,241 and 4,800,116 .
  • US 4106505 discloses a cannular having a body portion and a pair of nare formations, which is formed by dip moulding. The cannula disclosed in this specification does not however include a mouth piece. US4106505 does not include any details of the mandrel assembly used in the dip moulding process.
  • EP-A-0 933 094 discloses a cannula having a main body, first and second nares and a mouthpiece.
  • US-A-3 731 900 discloses a method of molding a nasal cannula using a unitary core or separate cores for the main body and the nasal tips.
  • SUMMARY OF THE INVENTION
  • It is an object of the invention to provide a method of manufacturing cannulas using an assembly of disconnectable mandrels over which cannula forming polymeric material is applied. Application of the plastics material over the mandrel assembly and subsequent extraction of the mandrel sections following curing of the cannula material provides a finished cannula with contiguous internal flow paths to monitor a patent's breathing.
  • It is a further object of the invention to provide a multi-part mandrel assembly for forming a cannula which facilitates extraction of the mandrel assembly sections after at least partial curing the polymeric material forming the cannula.
  • Still another object of the invention is to form the main body forming mandrel as two separate, slightly spaced apart components which remain spaced apart from one another by a void, during the dipping process, so that the void becomes filled with a plastisol to form a septum or barrier which divides the internal passage into two compartments or passageways, one which facilitates the supply of supplemental oxygen to a patient while the other facilitates monitoring of the breathing of the patient.
  • According to the invention, there is provided a method of forming a cannula according to claim 1.
  • Also according to the invention there is provided a cannula mandrel assembly according to claim 9.
  • Preferred embodiments are defined in the dependent claims. Any embodiments, aspects and examples disclosed herein, but not falling under the scope of the claims, do not form part of the invention.
  • . BRIEF DESCRIPTION OF THE DRAWINGS.
    • . The invention will now be described, by way of example, with reference to the accompanying drawings, in which:
    • . Fig. 1 is an orthogonal view of a cannula mandrel assembly with cannula forming polymeric material shown in ghost;
    • . Fig. 2 is an orthogonal view of the cannula mandrel parts prior to assembly;
    • . Fig. 3 is a side elevation of the mouthpiece mandrel of Figs. 1 and 2 showing an end connector;
    • . Fig. 4 is an end section of the end connector taken on section 4-4 of Fig. 3;
    • . Fig. 5 is a fragmentary side elevation of the main body mandrel of Figs. 1 and 2 taken in the direction of arrow 5 in Fig. 2;
    • . Fig. 6 is an elevation of the main body mandrel taken in the direction of arrow 6 in Fig. 5;
    • . Fig. 7 is a general cross-section of a cannula made by the method of the present invention taken in the direction of section 7-7 of Fig. 1;
    • . Fig. 8 is a flow diagram of the method of the present invention; and
    • . Fig. 9 is an orthogonal view of a cannula mandrel assembly for forming a septum or barrier in a void of the main body forming mandrel, with cannula forming polymeric material shown in ghost.
    . DETAILED DESCRIPTION OF THE EMBODIMENTS
  • Referring to Fig. 1, the main body forming mandrel 1 of a beryllium copper cannula mandrel assembly 3 is shown with nare forming mandrels 5 and 7, and a mouthpiece forming mandrel 9 with end connector 11, for joining the mouthpiece
  • mandrel 9 to the main body forming mandrel 1. Shown in ghost is a cannula formed on the assembly and comprising a main body 1', a pair of nares 5', 7'and a mouthpiece 9'composed of polyvinyl chloride (PVC).
  • Fig. 2 shows the mandrel assembly parts prior to assembly to produce the cannula mandrel assembly 3. Nare mandrels 5 and 7 have reduced diameter sections 13 and 15 to form nares 5', 7', respectively, over which cannula material is applied. Reduced diameter sections 13 and 15 of nare mandrels 5 and 7 mate slidably with blind holes 17 and 19 of main body mandrel 1. Main body mandrel 1 also has a rectangular recessed section 21 to slidably mate with end connector 11 of mouthpiece mandrel 9.
  • Nare mandrels 5 and 7 also have enlarged diameter sections 23 and 25 to support the mandrel in a jig. Additionally, the enlarged diameter enables sections 23 and 25 to provide a larger contact surface to provide grip for removal of nare mandrels 5 and 7 from main body mandrel 1 after partial curing of the PVC on mandrel assembly 3.
  • Fig. 2 further shows the mouthpiece mandrel 9 with the end connector 11 which has a slot 27 to slidably engage the rectangular section 21 of the main body mandrel 1. Slot 27 is sized to permit close contact of slot 27 with the rectangular section 21 of main body mandrel 1 such that a snug fit is obtained to removably retain the mouthpiece mandrel 9 on the main body mandrel 1 while facilitating extraction from rectangular section 21 following partial curing and cooling of the PVC. The outer surface of end connector 11 approximates the outer diameter of main body mandrel 1 to provide a uniform diameter of applied cannula material and to facilitate withdrawal of the mouthpiece mandrel 9 from the mouthpiece 9'of the canula.
  • Fig. 3 shows mouthpiece mandrel 9 having a desired radius X and end connector 11 with slot 27.
  • Fig. 4 shows the shape of end connector 11 and slot 27 through section 4-4 of Fig. 3.
  • Referring to Figs. 5 and 6, blind holes 17 and 19 are sized to mate slidably with reduced diameter sections 13 and 15 of the nare mandrels 5 and 7 in order to engage and support nare mandrels 5 and 7 during application of the PVC to form the cannula on the assembly 3. The rectangular section 21 is made with shoulder depth T removed to allow the diameter of end connector 11 of mouthpiece mandrel 9 to mate approximately flush with the diameter Y of main body 1.
  • Rectangular section 21 is shown with preferred relieving radii R at opposed ends of the section. Radius R may be omitted if main body mandrel 1 is machined or formed in a manner that allows this. Thickness Z of rectangular section 21 permits slot 27 of end connector 11 of mouthpiece mandrel 9 to firmly but slidably mate with rectangular section 21. Width W of rectangular section 21 is just sufficient to closely accommodate end connector 11 of mouthpiece mandrel 9.
  • Figs. 1 and 2 show nare mandrels 5 and 7 with bend sections. These bend sections direct the nares of the cannula into a patient's nasal cavities.
  • Although beryllium copper is the preferred material for the cannula mandrel assembly 3, other materials which possess appropriate working temperature ranges, retain dimensional stability for reuse in a manufacturing environment and which will release the cannula easily after curing of the PVC may be used. Metals including but not limited to the steels, aluminum, bronze, brass, and copper alloys may be used, as well as some plastics. Beryllium copper is preferred due to its ability to transfer heat rapidly and reliably release the cured plastics material of the cannula formed thereon. Rapid heat transfer is desirable for the mandrel material, both during heating cannula mandrel assembly 3 and following cannula material application, when a partial cure of the material is followed by rapid cooling.
  • Prior to application of a latex solution of PVC (plastisol) the cannula mandrel 3 is coated, usually by dipping, with a silicone release layer to facilitate removal of the mandrel from the plastisol to be applied. The application of the PVC in the preferred embodiment is by dipping the silicone coated cannula mandrel assembly 3 which has been heated in an oven at an oven temperature of from about 176.6°C (350°F) to about 290.6°C (550°F) (preferably about 232.2 °C (450°F)) for about 1 to about 3 minutes into a latex solution of PVC (plastisol). One or more dipping steps may be performed to achieve the desired finished cannula material thickness and each of these dipping steps may
    be for 10-30 seconds. During dipping the mandrel is supported by the outer end portions of the nare mandrels.
  • The preferred use of a latex solution of PVC (plastisol) provides a semi-clear finished cannula with strength to withstand attachment of connectors and flexibility to prevent injury to the user. Alternatively, other plastics materials, which provide material properties suitable for this method, capable of forming a plastisol may be substituted for PVC.
  • Partial curing of the cannula takes place on the mandrel assembly 3. The cannula mandrel assembly with the partially cured PVC thereon is then placed in an oven a sufficient time for further curing at a temperature from about 210.0°C (410°F) to about 232.2°C (450°F). Following curing to stabilize the PVC and after the cannula has cooled sufficiently to allow mandrel removal with the assistance of the release layer, without damaging the cannula, while providing sufficient physical strength to retain cannula shape, the mandrel parts are removed from the cannula.
  • Using the inventive method, a cannula with two nares and a mouthpiece is formed as follows: a cannula mandrel assembly 3 is formed by first, slidably mating reduced diameter sections 13 and 15 of nare mandrels 5 and 7 with blind holes 17 and 19, respectively, of the main body mandrel1 ; second, orienting nare mandrels 5 and 7; third, slidably mating slot 27 of end connector 1-1 of the mouthpiece mandrel 9 with the rectangular section 21 of main body mandrel 1 in a desired orientation relative to nare mandrels 5 and 7; fourth, providing a silicone release layer substantially encompassing the mandrel; fifth, heating the assembled cannula mandrel assembly in an oven at a temperature of from about 176.6°C (350°F) to about 290.6°C (550°F); sixth, providing a liquid uncured latex PVC mix (plastisol); seventh, dipping the cannula mandrel assembly into the plastisol, at least once, until the desired material thickness on the assembly is achieved; eighth, at least partially curing the PVC at a temperature of about 210.0°C (410°F) to from about 232.2°C (450°F); and ninth, removing the nare mandrels 5 and 7 from the blind holes 17 and 19 of main body mandrel 1 and the nares 5', 7' by pulling on enlarged diameter sections of nare mandrels 5 and 7, removing mouthpiece mandrel 9 from the mouthpiece 9' by disconnecting slot 27 of end connector 11 from rectangular section 21 of main body mandrel 1 and pulling
    the mouthpiece mandrel 9 through the mouthpiece 9'; and finally slidably removing main body mandrel 1 from the main body 1' of the cannula.
  • Fig. 7 show a finished cannula, following removal of cannula mandrel assembly 3 parts from the cured PVC, showing contiguous flow paths through the main body 1', nares 5' and 7' and mouthpiece 9'.
  • It will be appreciated that the curing step may be completed in two stages, a first partial cure of the PVC produced by the heated cannula mandrel assembly 3 sufficient to maintain the PVC on this assembly and a second step in an oven at the above curing temperatures to complete the curing of the PVC.
  • It will be further appreciated that the outer ends of the main body 1' may be trimmed to provide a discrete area where connecting tubing may be connected thereto, e.g. by solvent bonding, and that the mouthpiece may be trimmed to a length suited to an individual patient so as to maximize the sensitivity of the finished device.
  • It will also be understood that disassembly of the cannula mandrel assembly, following cannula material cure, can proceed by removing the mouthpiece mandrel before the nare mandrels as obvious alternative method steps, prior to removal of the main body mandrel.
  • One modification of the present invention relates to the addition of a septum in the internal passage of the cannula to provide a barrier therein. The septum 29 divides the internal passage into two compartments or passageways so that a first one of the nares 5' can be coupled to an oxygen source (not shown) to facilitate the supply of supplemental oxygen to one of the nostrils of a patient while the other one of the nares 7' and the central mouthpiece 9' can be coupled to a monitoring device (not shown), such as a transducer, to facilitate monitoring of breathing of the patient or coupled to a demand oxygen conserving device (not shown) while the patient, at the same time, is still able to receive, either continuously or intermittently during the sensed breathing cycle, a supply of oxygen.
  • To manufacture the septum 29, the main body forming mandrel 1 is formed as first and second separate, slightly spaced apart components 30,31 which remain spaced apart from one another by a void 32 during the dipping operation of the manufacturing process so that the void 32 between the first and second separate, slightly spaced apart components 30, 31 is filled with the plastisol to form the septum 29. Once the cannula is cured, the septum 29 forms a barrier which divides the internal passage into two compartments or passageways.
  • Following sufficient curing, the nare mandrels 5 and 7 are removed from the blind holes 17 and 19 of main body mandrel 1 and the nares 5', 7' by pulling on enlarged diameter sections of nare mandrels 5 and 7, the mouthpiece mandrel 9 is removed from the mouthpiece 9' by disconnecting slot 27 of end connector 11 from rectangular section 21 of main body mandrel 1 and pulling the mouthpiece mandrel 9 through the mouthpiece 9'; and the first and second spaced apart components 30, 31 of the main body mandrel 1 are removed from the main body 1' of the cannula by pulling the first and second spaced apart components 30, 31 axially away from one another.
  • This variation of the manufacturing process is suitable for intermittent nocturnal oxygen delivery even though the patient breaths through his or her mouth. Reference numerals
    1 main body mandrel 19 blind hole
    1' main body 21 rectangular recessed section
    3 cannula mandrel assembly 23 enlarged diameter section
    5 nare mandrel 25 enlarged diameter section
    5' nare mandrel 27 slot
    7 nare mandrel
    7' nare R radius
    9 mouthpiece mandrel T rectangular section shoulder depth
    9' mouthpiece
    11 end connector W rectangular section width
    13 reduced diameter section X mouthpiece mandrel radius
    15 reduced diameter section Y main body diameter
    17 blind hole Z rectangular section thickness

Claims (11)

  1. A method of forming a cannula comprising the steps of providing parts for forming a cannula mandrel assembly (3), the parts comprising a pair of nare forming mandrels (5, 7) each defining an end,
    a main body forming mandrel (1) having a rectangular central recessed section (21) and openings (17, 19) to receive and engage the ends of the nare forming mandrels (5, 7), and a mouthpiece forming mandrel (9) having an end connector (11), the end connector (11) defining a slot (27) dimensioned to mate slidingly with the central recessed section (21);
    assembling the parts to form the cannula mandrel assembly (3) defining interior spaces of the cannula to be formed; heating the cannula mandrel assembly (3) to a desired temperature;
    providing an uncured cannula forming polymeric material in a flowable state;
    dipping the heated cannula mandrel assembly (3) in the polymeric material to form a desired thickness of partially cured polymeric material on the cannula mandrel assembly (3) for forming the cannula;
    heating the partially cured polymeric material on the cannula mandrel assembly (3) to further cure the polymeric material; and
    extracting, from the cured polymeric material, the nare forming mandrels (5, 7), the mouthpiece forming mandrel (9) by removing the slot (27) from the rectangular central recessed section (21), and the main body forming mandrel (1) to produce the cannula.
  2. A method according to claim 1 characterized in that the main body forming mandrel comprises separate first and second components with a void (32) formed therebetween, said rectangular central recessed section (21) being formed in one of the first and second components and an opening being formed in each said first and second components to receive and engage the end of one of the n are forming mandrels (5, 7).
  3. A method according to claim 1 or 2 characterized in that the cannula mandrel assembly (3) is manufactured from beryllium copper.
  4. A method according to any one of the preceding claims characterized in that the cannula mandrel assembly (3) is heated to a temperature of from about 176.6°C (350°F) to about to about 290.6°C (550°F).
  5. A method according to any one of the preceding claims characterized in that the cannula mandrel assembly (3) is coated with a layer of release material prior to dipping in the polymeric material.
  6. A method according to any one of the preceding claims characterized in that the polymeric material is applied by a plurality of dipping steps.
  7. A method according to any one of the preceding claims characterized in that the polymeric material is at least partially cured at a temperature of from about 210.0°C (410°F) to about 232.2°C (450°F).
  8. A method according to any one of the preceding claims characterized in that the end connector (11) of the mouthpiece mandrel (9) is provided with an outer surface about the slot (27) having a dimension which is the same as a main dimension of the main body portion to ensure that the nasal cannula is formed having a substantially constant inner diameter.
  9. A cannula mandrel assembly (3), defining the interior cavity of a cannula having a main body, first and second nares and a mouthpiece, the cannula mandrel assembly (3) comprising a main body forming mandrel (3) and a pair of nare forming mandrels (5', 7'),
    the main body forming mandrel (3) defines openings for releasably engaging the nare forming mandrels (5', 7'), the mandrel assembly (3) also comprising an elongate mouthpiece forming mandrel (9) having an end connector (11) defining a slot (27),
    the main body forming mandrel (1) also defining a central recessed rectangular section (21) slidably receiving, engaging and supporting the end connector slot (27) of the mouthpiece forming mandrel (9); and
    the main body forming mandrel (3) comprises two separate components (1, 31).
  10. A cannula mandrel assembly (3) according to claim 9 characterized in that the two separate components (1, 31) define a void (32) therebetween for forming a septum (29).
  11. A cannula mandrel assembly (3) to claim 10, characterized in that the recessed rectangular section (21) is provided in one of the two components and each component is provided with and opening for one of the nare forming mandrels.
EP01992093.3A 2001-01-04 2001-12-12 Method to produce nasal and oral cannula breathing detection devices Expired - Lifetime EP1360050B1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US754471 2001-01-04
US09/754,471 US6533983B2 (en) 2001-01-04 2001-01-04 Method to produce nasal and oral cannula apnea detection devices
US883843 2001-06-18
US09/883,843 US6533984B2 (en) 2001-01-04 2001-06-18 Method to produce nasal and oral cannula breathing detection devices
PCT/US2001/048154 WO2002053346A1 (en) 2001-01-04 2001-12-12 Method to produce nasal and oral cannula breathing detection devices

Publications (3)

Publication Number Publication Date
EP1360050A1 EP1360050A1 (en) 2003-11-12
EP1360050A4 EP1360050A4 (en) 2007-04-04
EP1360050B1 true EP1360050B1 (en) 2017-02-15

Family

ID=27115922

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01992093.3A Expired - Lifetime EP1360050B1 (en) 2001-01-04 2001-12-12 Method to produce nasal and oral cannula breathing detection devices

Country Status (6)

Country Link
US (2) US6533984B2 (en)
EP (1) EP1360050B1 (en)
JP (1) JP4170094B2 (en)
AU (1) AU2002232567B2 (en)
CA (1) CA2433294C (en)
WO (1) WO2002053346A1 (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7178524B2 (en) * 1998-10-30 2007-02-20 Linda Noble Nasal gas delivery system and method for use thereof
US7047969B2 (en) * 1998-10-30 2006-05-23 Linda Noble Nasal gas delivery system and method for use thereof
US6595215B2 (en) * 2000-03-13 2003-07-22 Innomed Technologies, Inc. Ventilation interface for sleep apnea therapy
US7832400B2 (en) * 2001-01-04 2010-11-16 Salter Labs Nasal and oral cannula having two capabilities and method of producing same
US7743770B2 (en) * 2001-01-04 2010-06-29 Salter Labs Nasal and oral cannula having three or more capabilities and method of producing same
US7337780B2 (en) * 2001-01-04 2008-03-04 Salter Labs Nasal and oral cannula breathing detection device
IL180964A (en) * 2002-09-05 2010-11-30 Inventio Ag Drive engine for a lift installation and method of mounting a drive engine
US20050165366A1 (en) * 2004-01-28 2005-07-28 Brustad John R. Medical tubing having variable characteristics and method of making same
US20050004515A1 (en) 2002-11-15 2005-01-06 Hart Charles C. Steerable kink resistant sheath
WO2005035021A2 (en) * 2003-10-07 2005-04-21 Noble Linda J A nasal gas delivery system and method for use thereof
US20050092329A1 (en) * 2003-10-29 2005-05-05 Sta-Maria Rosalinda C. Nasal continuous positive airway pressure cannula device and securement for infants
US7837651B2 (en) * 2004-08-31 2010-11-23 Ethicon Endo-Surgery, Inc. Infusion pump
US7171962B1 (en) * 2005-01-14 2007-02-06 Gloria Turner Bloem Soft oral airway for intravenous anesthesia and method of use
US7565907B2 (en) * 2005-06-17 2009-07-28 Salter Labs Nasal and oral cannula having two capabilities and method of producing same
US11497407B2 (en) 2005-09-12 2022-11-15 ResMed Pty Ltd High flow therapy device utilizing a non-sealing respiratory interface and related methods
US11833301B2 (en) 2005-09-12 2023-12-05 ResMed Pty Ltd High flow therapy device utilizing a non-sealing respiratory interface and related methods
US11717174B2 (en) 2005-09-12 2023-08-08 ResMed Pty Ltd High flow therapy device utilizing a non-sealing respiratory interface and related methods
US11696992B2 (en) 2005-09-12 2023-07-11 ResMed Pty Ltd High flow therapy device utilizing a non-sealing respiratory interface and related methods
US11458270B2 (en) 2005-09-12 2022-10-04 ResMed Pty Ltd High flow therapy device utilizing a non-sealing respiratory interface and related methods
EP1979030A2 (en) * 2005-12-14 2008-10-15 Mergenet Medical Inc. High flow therapy device utilizing a non-sealing respiratory interface and related methods
EP2018336B1 (en) 2006-05-18 2018-08-22 Applied Medical Resources Corporation Method of making medical tubing having variable characteristics using thermal winding
US11318267B2 (en) 2006-09-12 2022-05-03 ResMed Pty Ltd High flow therapy device utilizing a non-sealing respiratory interface and related methods
US8056562B2 (en) * 2006-09-28 2011-11-15 Nellcor Puritan Bennett Llc System and method for providing support for a breathing passage
US7946288B2 (en) * 2006-11-10 2011-05-24 Encompas Unlimited, Inc. Bite block system and method
AU2009206372A1 (en) * 2008-01-25 2009-07-30 Salter Labs Respiratory therapy system including a nasal cannula assembly
EP3300758B1 (en) 2013-03-15 2019-05-29 Airway Control Technologies, LLC Medical breathing apparatus
US9925348B2 (en) 2013-07-17 2018-03-27 Upods, Llc Gas delivery device
US9440039B2 (en) 2013-07-17 2016-09-13 Upods, Llc Gas delivery device
USD744637S1 (en) * 2013-10-08 2015-12-01 Koninklijke Philips N.V. Cannula nosepiece
CN107696366B (en) * 2017-11-16 2024-03-08 宁波圣宇瑞医疗器械有限公司 Nose immersion mould
USD957622S1 (en) * 2019-10-16 2022-07-12 Aires Medical LLC Nasal cannula
CN117244146B (en) * 2023-11-20 2024-02-09 上海埃立孚医疗科技有限公司 Oxygen inhalation device for laryngeal operation

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2053357A (en) * 1934-03-28 1936-09-08 American Anode Inc Apparatus for making therapeutical appliances
US2296011A (en) * 1940-04-06 1942-09-15 American Anode Inc Deposition form
US2854695A (en) * 1956-06-13 1958-10-07 Davol Rubber Co Catheter molding form
US2824407A (en) * 1956-06-27 1958-02-25 Oak Rubber Company Balloon with integral tie
US3643660A (en) * 1969-11-21 1972-02-22 Allan C Hudson Nasal cannula
US3931381A (en) * 1970-09-04 1976-01-06 The General Tire & Rubber Company Mold release method for polyurethane integral-skin foam
US3731900A (en) * 1971-03-22 1973-05-08 Hudson Oxygen Therapy Sales Co Unitary core for molding a nasal cannula
US3802431A (en) 1971-10-08 1974-04-09 Bard Inc C R Nasal cannula
FR2197613B1 (en) * 1972-08-29 1981-06-12 Guichard Paul
US3906071A (en) 1973-04-30 1975-09-16 Leon Chemical & Plastics Div O Dip molding process
US4106505A (en) * 1977-01-17 1978-08-15 Salter Labs., Inc. Nasal cannula assembly
US4152688A (en) 1978-03-27 1979-05-01 Dietz Henry G Air flow switch
US4433219A (en) 1982-02-22 1984-02-21 Dietz Henry G Differential pressure switch with square diaphragm plate supported by the diaphragm
US4818320A (en) * 1984-04-04 1989-04-04 Sherwood Medical Company Nasal cannula harness and method of making the same
US4878502A (en) 1984-08-31 1989-11-07 Dietz Henry G Breathing sensor
US4602643A (en) 1984-09-14 1986-07-29 Dietz Henry G Pneumatic breathing belt sensor with minimum space maintaining tapes
US4800116A (en) 1985-02-27 1989-01-24 Sinclair And Rush, Inc. Dip molding process and article
US4695241A (en) 1986-01-24 1987-09-22 Sinclair And Rush, Inc. Dip mold and process
US5052400A (en) 1986-02-20 1991-10-01 Dietz Henry G Method and apparatus for using an inhalation sensor for monitoring and for inhalation therapy
US4745925A (en) 1986-10-06 1988-05-24 Dietz Henry G Optoelectronic inhalation sensor for monitoring inhalation and for inhalation therapy
US5024219A (en) 1987-01-12 1991-06-18 Dietz Henry G Apparatus for inhalation therapy using triggered dose oxygenator employing an optoelectronic inhalation sensor
US5335656A (en) * 1988-04-15 1994-08-09 Salter Laboratories Method and apparatus for inhalation of treating gas and sampling of exhaled gas for quantitative analysis
US5074299A (en) 1988-05-02 1991-12-24 Dietz Henry G Monitor for controlling the flow of gases for breathing during inhalation
US5005571A (en) 1988-11-25 1991-04-09 Dietz Henry G Mouth nose mask for use with an inhalation therapy and/or breathing monitoring apparatus
US5111904A (en) * 1989-06-02 1992-05-12 Minnesota Mining And Manufacturing Company Molded article having elastomeric mold member used therewith
US5038771A (en) 1990-01-25 1991-08-13 Dietz Henry G Method and apparatus for respiratory therapy using intermittent flow having automatic adjustment of a dose of therapeutic gas to the rate of breathing
US5046491A (en) * 1990-03-27 1991-09-10 Derrick Steven J Apparatus and method for respired gas collection and analysis
RU1775957C (en) * 1990-07-19 1995-09-10 Научно-производственное предприятие "Ярсинтез" Mold for making dipped articles
RU1793628C (en) * 1990-07-19 1995-10-10 Научно-производственное объединение "Ярсинтез" Macaroni products die
US5133923A (en) * 1991-05-06 1992-07-28 Sierra Laboratories, Inc. Method of simultaneously forming container strap holders on urinary latex containers
US5485850A (en) 1993-08-13 1996-01-23 Dietz; Henry G. Monitor of low pressure intervals with control capabilities
US5513634A (en) * 1994-05-06 1996-05-07 Chek-Med Systems, Inc. Combination integral bite block airway and nasal cannula
US5485833A (en) 1994-06-10 1996-01-23 Dietz; Henry G. Breath exposure synchronizer
US6217818B1 (en) * 1995-07-07 2001-04-17 Continental Pet Technologies, Inc. Method of making preform and container with crystallized neck finish
US5682881A (en) * 1996-10-21 1997-11-04 Winthrop; Neil Nasal CPAP/Cannula and securement apparatus
US5922365A (en) * 1997-08-18 1999-07-13 Reichner; Patrick Ernest Apparatus for dip-molding and enclosed loop
IL123122A0 (en) * 1998-01-29 1998-09-24 Oridion Medical Ltd Oral/nasal cannula
DE19845960A1 (en) * 1998-10-06 2000-04-13 Insta Elektro Gmbh & Co Kg Electrical installation system
US6247470B1 (en) * 1999-07-07 2001-06-19 Armen G. Ketchedjian Oxygen delivery, oxygen detection, carbon dioxide monitoring (ODODAC) apparatus and method
US6635214B2 (en) * 1999-09-10 2003-10-21 Ventrica, Inc. Manufacturing conduits for use in placing a target vessel in fluid communication with a source of blood
US6379312B2 (en) * 1999-12-28 2002-04-30 O'toole James End tidal carbon dioxide sampling device
US6910876B2 (en) * 2001-05-16 2005-06-28 The Goodyear Tire & Rubber Company Mandrel for forming a curved hose

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
None *

Also Published As

Publication number Publication date
JP4170094B2 (en) 2008-10-22
CA2433294C (en) 2010-09-14
CA2433294A1 (en) 2002-07-11
EP1360050A1 (en) 2003-11-12
US20030030183A1 (en) 2003-02-13
US6830445B2 (en) 2004-12-14
US6533984B2 (en) 2003-03-18
JP2004523380A (en) 2004-08-05
US20020121729A1 (en) 2002-09-05
AU2002232567B2 (en) 2006-06-15
WO2002053346A1 (en) 2002-07-11
EP1360050A4 (en) 2007-04-04

Similar Documents

Publication Publication Date Title
EP1360050B1 (en) Method to produce nasal and oral cannula breathing detection devices
AU2002232567A1 (en) Method to produce nasal and oral cannula breathing detection devices
US7832400B2 (en) Nasal and oral cannula having two capabilities and method of producing same
US7743770B2 (en) Nasal and oral cannula having three or more capabilities and method of producing same
US8074652B2 (en) Nasal and oral cannula having two capabilities and method of producing same
US7337780B2 (en) Nasal and oral cannula breathing detection device
US6533983B2 (en) Method to produce nasal and oral cannula apnea detection devices
US7357845B2 (en) Methods of making laryngeal masks
US7364682B2 (en) Nasal and oral cannula breathing detection device
GB2407294A (en) Method of making laryngeal masks
JPH0542552A (en) Manufacture of medical tube

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20030829

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

A4 Supplementary search report drawn up and despatched

Effective date: 20070306

17Q First examination report despatched

Effective date: 20080319

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

RIC1 Information provided on ipc code assigned before grant

Ipc: B29C 41/22 20060101ALI20160608BHEP

Ipc: B29C 41/14 20060101AFI20160608BHEP

Ipc: A61M 16/06 20060101ALI20160608BHEP

Ipc: B29C 33/48 20060101ALI20160608BHEP

INTG Intention to grant announced

Effective date: 20160714

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DE

Ref legal event code: R081

Ref document number: 60150324

Country of ref document: DE

Owner name: SALTER LABS LLC, CARLSBAD, US

Free format text: FORMER OWNER: SALTER LABS, ARVIN, CALIF., US

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 867648

Country of ref document: AT

Kind code of ref document: T

Effective date: 20170315

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 60150324

Country of ref document: DE

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20170215

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 867648

Country of ref document: AT

Kind code of ref document: T

Effective date: 20170215

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170215

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170516

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170215

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170215

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170215

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170615

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170215

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170215

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 60150324

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170215

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 17

26N No opposition filed

Effective date: 20171116

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20171212

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20171231

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20171212

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20171231

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20171231

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20171231

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170215

REG Reference to a national code

Ref country code: DE

Ref legal event code: R082

Ref document number: 60150324

Country of ref document: DE

Representative=s name: HAFT - KARAKATSANIS PATENTANWALTSKANZLEI, DE

Ref country code: DE

Ref legal event code: R081

Ref document number: 60150324

Country of ref document: DE

Owner name: SALTER LABS LLC, CARLSBAD, US

Free format text: FORMER OWNER: SALTER LABS, ARVIN, CALIF., US

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20170215

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20170215

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20200615

Year of fee payment: 19

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20200608

Year of fee payment: 19

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20200630

Year of fee payment: 19

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 60150324

Country of ref document: DE

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20201212

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20201231

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20201212

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210701